Trial Profile
Efficacy and Safety of Low Dose Prasugrel in Japanese Acute Coronary Syndrome Patients: A Single-center Prospective Clinical Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Oct 2018
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 08 Oct 2018 Status changed from recruiting to completed.
- 29 Aug 2018 Results (n=1167) presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology.
- 06 Oct 2015 New trial record